ArticleFrontiers in oncology2023

Development, comparison, and validation of four intelligent, practical machine learning models for patients with prostate-specific antigen in the gray zone.

Taobin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.